All News about NeoGenomics, Inc. - Common Stock
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4985.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/722031/group-of-medical-practitioners-having-a-seminar-in-board-room.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/neo_logo_light__f612f0a03c8869c1905cf6f46a8a968c.png?width=1200&height=800&fit=crop)
Why NeoGenomics Shares Are Trading Higher Today
February 23, 2023
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
NeoGenomics Reports Fourth Quarter and Full Year 2022 Results
February 23, 2023
Via ACCESSWIRE
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for NeoGenomics's Future
February 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/23/image33.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/image-dominos.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Thursday's Intraday Session
February 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/23/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/23/image30.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230208005832/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_123.jpeg?width=1200&height=800&fit=crop)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](https://mms.businesswire.com/media/20230206005002/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Topics
Lawsuit
![](https://mms.businesswire.com/media/20230203005449/en/1510725/22/Latest_KSF_SEC.jpg)
![](https://mms.businesswire.com/media/20230203005026/en/538768/22/BES_Mark.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20230203005088/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2531.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
Via Benzinga
Via NewMediaWire
Topics
Lawsuit
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](https://mms.businesswire.com/media/20230124006136/en/1695310/5/GLG_securities_press_release_logo_NEO_Hotline_%281%29.jpg)
NEO INVESTOR ALERT: First and Only NeoGenomics Class Action Filed by Gibbs Law Group
January 24, 2023
From Gibbs Law Group
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.